Sumitomo Mitsui Trust Holdings, Inc. Adaptive Biotechnologies Corp Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $138 Billion
- Q1 2025
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 6,085,690 shares of ADPT stock, worth $64.1 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
6,085,690
Previous 6,833,137
10.94%
Holding current value
$64.1 Million
Previous $41 Million
10.29%
% of portfolio
0.03%
Previous 0.03%
Shares
21 transactions
Others Institutions Holding ADPT
# of Institutions
245Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$316 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$138 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$123 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$117 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$81.4 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.5B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...